Sensus Healthcare (Sensus Healthcare) GF Value : $6.46 (As of May. 10, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-10), Sensus Healthcare's share price is $5.08. Sensus Healthcare's GF Value is $6.46. Therefore, Sensus Healthcare's Price-to-GF-Value for today is 0.79.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Sensus Healthcare is Modestly Undervalued.

Sensus Healthcare (NAS:SRTS) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Sensus Healthcare's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	5.08	/	6.46
	=	0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sensus Healthcare GF Value Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Sensus Healthcare (Sensus Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

5TX:Germany

Address

851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487

Website

https://www.sensushealthcare.com

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Executives

Joseph C Sardano	director, officer: Chief Executive Officer	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Michael Sardano	officer: GENERAL COUNSEL	851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
John Heinrich	director	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Samuel O'rear	director	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez	officer: Chief Operating Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall	director	851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro	officer: Chief Operating Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Javier Rampolla	officer: Chief Financial Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen	officer: EXECUTIVE VICE PRESIDENT	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish	director	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price	officer: Chief Technology Officer	851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman	officer: CHIEF TECHNOLOGY OFFICER	851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin	officer: EXECUTIVE VICE PRESIDENT	851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487